SCHEMBL13799185

SCHEMBL13799185

Cc1cc(-c2ccccn2)cc(C)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.58
▸ NPC1 O15118 4/20 0.58
▸ LMNA P02545 3/20 0.52
▸ CCR1 P32246 3/20 0.52
▸ CCR5 P51681 3/20 0.52
▸ CCR8 P51685 3/20 0.52
▸ POLB P06746 2/20 0.52
▸ METAP1 P53582 2/20 0.52
▸ CYP1A2 P05177 2/20 0.52
▸ BLM P54132 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ DOHH Q9BU89 1/20 0.52
▸ P4HTM Q9NXG6 1/20 0.52
▸ CYP2A6 P11509 1/20 0.47
▸ KAT6A Q92794 1/20 0.45
▸ TP53 P04637 4/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ ALOX15 P16050 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8824445 0.84 KDM4E (0.55) KDM4ENPC1LMNACCR1CCR5
SCHEMBL15262815 0.84 KDM4E (0.55) KDM4ENPC1LMNACCR1CCR5
SCHEMBL13799201 0.84 KDM4E (0.55) KDM4ENPC1LMNACCR1CCR5
SCHEMBL16672906 0.82 KDM4E (0.68) KDM4ENPC1LMNACCR1CCR5
SCHEMBL7662434 0.82 KDM4E (0.56) KDM4ENPC1LMNACCR1CCR5
SCHEMBL3851861 0.81 KDM4E (0.55) KDM4ENPC1LMNACCR1CCR5
SCHEMBL991104 0.81 KDM4E (0.55) KDM4ENPC1LMNACCR1CCR5
SCHEMBL29871087 0.81 KDM4E (0.55) KDM4ENPC1LMNACCR1CCR5
SCHEMBL14426234 0.80 KDM4E (0.65) KDM4ENPC1LMNACCR1CCR5
SCHEMBL18561779 0.80 KDM4E (0.54) KDM4ENPC1LMNACCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10886477-B2 Iridium complex and organic electroluminescence device using the same UDC IRELAND LIMITED (IE) 2021-01-05 — — US disclosed
US-10886477-B2 Iridium complex and organic electroluminescence device using the same UDC IRELAND LIMITED (IE) 2021-01-05 — — US disclosed
CN-110294778-A Iridium compound and the organic electroluminescent element for using it 机光科技股份有限公司 2019-10-01 — — CN disclosed
US-20190296251-A1 IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-09-26 — — US disclosed
US-20190296251-A1 IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-09-26 — — US disclosed
US-8778508-B2 Light-emitting organometallic complexes UNIVERSAL DISPLAY CORPORATION (US) 2014-07-15 — — US disclosed
US-8778508-B2 Light-emitting organometallic complexes UNIVERSAL DISPLAY CORPORATION (US) 2014-07-15 — — US disclosed
US-8519130-B2 Method for synthesis of iriduim (III) complexes with sterically demanding ligands UNIVERSAL DISPLAY CORPORATION (US) 2013-08-27 — — US disclosed
US-8519130-B2 Method for synthesis of iriduim (III) complexes with sterically demanding ligands UNIVERSAL DISPLAY CORPORATION (US) 2013-08-27 — — US disclosed
WO-2009073245-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2009-06-11 — — WO disclosed
WO-2009073246-A1 METHOD FOR THE SYNTHESIS OF IRIDIUM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS UNIVERSAL DISPLAY CORPORATION (US) 2009-06-11 — — WO disclosed
US-20090124805-A1 METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS UNIVERSAL DISPLAY CORPORATION 2009-05-14 — — US disclosed
US-20090124805-A1 METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS UNIVERSAL DISPLAY CORPORATION 2009-05-14 — — US disclosed
US-20090108737-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES UNIVERSAL DISPLAY CORPORATION 2009-04-30 — — US disclosed
US-20090108737-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES UNIVERSAL DISPLAY CORPORATION 2009-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090108737-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES CRY1, LAGE3, CRY2 KDM4E 1922/4885NPC1 4708/4885LMNA 4024/4885
US-20190296251-A1 IRIDIUM COMPLEX AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IMPA1, LAGE3, OCIAD1 KDM4E 3501/4885NPC1 1967/4885LMNA 4457/4885
US-10886477-B2 Iridium complex and organic electroluminescence device using the same IMPA1, LAGE3, OCIAD1 KDM4E 3501/4885NPC1 1967/4885LMNA 4457/4885
US-20090124805-A1 METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS PAICS, ITPA, MPI KDM4E 4012/4885NPC1 4408/4885LMNA 4632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback